By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a ...

New research reveals how CD44-positive and CD44-negative cell states drive different osimertinib responses in EGFR-mutant ...

Scientists at Fred Hutch Cancer Center and Seattle Children's Hospital have a new vision for cancer's origins. They argue that our focus on DNA mutations has led us astray, and that we should look ...

Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor ...

Like every other cell in the human body, cancer cells also produce their own share of proteins for survival. During this ...

New single-cell analysis reveals clonal heterogeneity in pancreatic ductal adenocarcinoma driving therapy resistance and immune evasion.

T cells infiltrate small cell lung cancer tumors and can kill them without the MHC-I machinery these tumors typically switch ...

First NICE-recommended drug for anal cancer that has spread and cannot be removed through surgery recommended today and is available immediately on the NHS.

Researchers from VCU Massey Comprehensive Cancer Center recently demonstrated that the inhibition of glucosylceramide ...

MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful ...

Chimeric antigen receptor T-cell therapy, known as CAR-T, represents a major milestone in targeted cancer medicine. The ...